Flex-Thread™ Ulna Intramedullary Nail System

K222390 · Flower Orthopedics Corporation Dba Conventus Flower · HSB · Nov 21, 2022 · Orthopedic

Device Facts

• Record ID: K222390
• Device Name: Flex-Thread™ Ulna Intramedullary Nail System
• Applicant: Flower Orthopedics Corporation Dba Conventus Flower
• Product Code: HSB · Orthopedic
• Decision Date: Nov 21, 2022
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 888.3020
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The Flex-Thread™ Ulna Intramedullary Nail System is intended for use in the fixation of fractures and osteotomies of the ulna.

Device Story

The Flex-Thread™ Ulna Intramedullary Nail System is an orthopedic fixation device designed for the ulna. It consists of an intramedullary nail featuring a flexible threaded tip and cortical screws. The device is inserted into the intramedullary canal of the ulnar diaphysis via an antegrade approach. The flexible tip engages the canal, while cortical screws provide stability and articular support in the proximal ulna and olecranon. It is used by orthopedic surgeons in a clinical or surgical setting to stabilize fractures and osteotomies, facilitating bone healing through rigid internal fixation. The system is provided as a set of varying diameters and lengths to accommodate different patient anatomies.

Clinical Evidence

Bench testing only. No clinical data was provided. Mechanical performance was evaluated according to ASTM F1264, including static four-point bend, static torsion, bending fatigue, and bending fatigue of interlocking screws. Additional testing included insertion torque and implant tip deflection to confirm safety and efficacy.

Technological Characteristics

Intramedullary fixation rod system. Materials and design consistent with predicate Flex-Thread™ system. Diameters: 4.5mm, 6.5mm, 7.5mm. Lengths: 120mm to 290mm. Includes 10mm and 20mm end caps. Mechanical testing performed per ASTM F1264. Non-powered, mechanical device.

Indications for Use

Indicated for the fixation of fractures and osteotomies of the ulna in patients requiring intramedullary stabilization.

Regulatory Classification

Identification

An intramedullary fixation rod is a device intended to be implanted that consists of a rod made of alloys such as cobalt-chromium-molybdenum and stainless steel. It is inserted into the medullary (bone marrow) canal of long bones for the fixation of fractures.

Predicate Devices

• Conventus Flower Orthopedics Flex-Thread™ Distal Fibula Intramedullary Nail System (K202858)
• Synthes (Usa) Elastic Intramedullary Nail (Ein) System (Line Extension) (K042135)

Submission Summary (Full Text)

{0}------------------------------------------------

November 21, 2022

Image /page/0/Picture/1 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which consists of the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG" in blue, and then the word "ADMINISTRATION" in a smaller font size below that.

Flower Orthopedics Corporation DBA Conventus Flower Christina Rovaldi Sr. Manager, RA/QA 100 Witmer Road Horsham, Pennsylvania 19044

#### Re: K222390

Trade/Device Name: Flex-Thread™ Ulna Intramedullary Nail System Regulation Number: 21 CFR 888.3020 Regulation Name: Intramedullary Fixation Rod Regulatory Class: Class II Product Code: HSB Dated: October 26, 2022 Received: October 27, 2022

#### Dear Christina Rovaldi:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpm/pmn.cfm identifies.combination product submissions. The general controls provisions of the Act include requirements for annual registration. listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801): medical device reporting of medical device-related adverse events) (21 CFR 803) for

{1}------------------------------------------------

devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrl-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE(@fda.hhs.gov) or phone [phone] or 301-796-7100).

Sincerely,

Victoria A. Lilling -S Digitally signed by Victoria A. Lilling -S

Victoria Lilling, M.D. Assistant Director DHT6A: Division of Joint Arthroplasty Devices OHT6: Office of Orthopedic Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

### Indications for Use

Submission Number (if known)

K222390

Device Name

Flex-Thread™ Ulna Intramedullary Nail System

Indications for Use (Describe)

The Flex-Thread™ Ulna Intramedullary Nail System is intended for use in the fixation of fractures and osteotomies of the ulna.

Type of Use (Select one or both, as applicable)

( Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

#### CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff [e-mail]

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

K222390 - Page 1 of 2

# 510(k) Summary

21 CFR 807.92(a)(1)

Prepared on: 2022-11-17

| Contact Details | | | | 21 CFR 807.92(a)(1) |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------|-------------------------------------------------------------------|--|---------------------|
| Applicant Name | | Flower Orthopedics Corporation DBA Conventus Flower | | |
| Applicant Address | | 100 Witmer Road Suite 280 Horsham PA 19044 United States | | |
| Applicant Contact Telephone | | 2153234029 | | |
| Applicant Contact | | Mrs. Christina Rovaldi | | |
| Applicant Contact Email | | [e-mail] | | |
| Device Name | | | | 21 CFR 807.92(a)(2) |
| Device Trade Name | | Flex-Thread™ Ulna Intramedullary Nail System | | |
| Common Name | | Rod, Fixation, Intramedullary And Accessories | | |
| Classification Name | | Intramedullary Fixation Rod | | |
| Regulation Number | | 888.3020 | | |
| Product Code | | HSB | | |
| Legally Marketed Predicate Devices | | | | 21 CFR 807.92(a)(3) |
| Predicate # | Predicate Trade Name (Primary Predicate is listed first) | | | Product Code |
| K202858 | Conventus Flower Orthopedics Flex-Thread™ Distal Fibula Intrar | | | HSB |
| K042135 | | Synthes (Usa) Elastic Intramedullary Nail (Ein) System (Line Exte | | HSB |
| Device Description Summary | | | | 21 CFR 807.92(a)(4) |
| The Flex-Thread™ Ulna Intramedullary Nail System is comprised of an intramedullary fixation device with a flexible threaded tip to<br>engage the intramedullary canal of the ulnar diaphysis from an antegrade approach and cortical screws to provide stability and articular<br>support in the proximal ulna and olecranon. | | | | |
| Intended Use/Indications for Use | | | | 21 CFR 807.92(a)(5) |
| The Flex-Thread™ Ulna Intramedullary Nail System is intended for use in the fixation of fractures and osteotomies of the ulna. | | | | |
| Indications for Use Comparison | | | | 21 CFR 807.92(a)(5) |
| Both devices are used in the treatment of fractures and osteotomies. The proposed device offers treatment of fractures and osteotomies<br>of the ulna versus the predicate indications which offers the same treatment but for the fibula. The use of the device in a different<br>anatomic area is supported by the additional predicate identified within the same regulation. | | | | |
| Technological Comparison | | | | 21 CFR 807.92(a)(6) |

## Technological Comparison

This Traditional 510(k) is submitted to introduce a 4.5mm, 6.5mm and 7.5mm diameter nail in 120mm, 150mm, 210mm, 210mm, 210mm, 240mm, 270mm and 290mm lengths as well as additional end caps in 10mm and 20mm. The proposed additions to the Flex-Thread™ System have the same technological characteristics as the predicate device Flex-Thread™ System.

{4}------------------------------------------------

#### Non-Clinical and/or Clinical Tests Summary & Conclusions 21 CFR 807.92(b)

The Flex-Thread Ulna implants were subjected to several mechanical tests with the intent of proving substantial equivalence to a predicate device. The following tests were identified according to the consensus standard ASTM F1264 - Standard Specification and Test Methods for Intramedullary Fixation Devices:

· Static Four Point Bend

- · Static Torsion
· Bending Fatigue

· Bending Fatigue of Interlocking Screws

Additionally, insertion torque and implant tip deflection were considered to evaluate the safety and efficacy of the device.

#### Not Applicable

Non-clinical performance testing demonstrates that the Flex-Thread™ Una Intramedullary Nail System is substantially equivalent to the predicate device